FI940098A - Menetelmiä liikehermotautien hoitamiseksi käyttäen BDNF/NT-3/NGF -molekyyliperheen jäseniä - Google Patents
Menetelmiä liikehermotautien hoitamiseksi käyttäen BDNF/NT-3/NGF -molekyyliperheen jäseniä Download PDFInfo
- Publication number
- FI940098A FI940098A FI940098A FI940098A FI940098A FI 940098 A FI940098 A FI 940098A FI 940098 A FI940098 A FI 940098A FI 940098 A FI940098 A FI 940098A FI 940098 A FI940098 A FI 940098A
- Authority
- FI
- Finland
- Prior art keywords
- bdnf
- treatment
- molecules
- members
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Physical Water Treatments (AREA)
- Water Treatment By Electricity Or Magnetism (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Water Treatment By Sorption (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
- Separation Of Suspended Particles By Flocculating Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72770491A | 1991-07-10 | 1991-07-10 | |
PCT/US1992/004228 WO1993001300A1 (en) | 1991-07-10 | 1992-05-19 | Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
Publications (2)
Publication Number | Publication Date |
---|---|
FI940098A0 FI940098A0 (fi) | 1994-01-10 |
FI940098A true FI940098A (fi) | 1994-03-10 |
Family
ID=24923677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI940098A FI940098A (fi) | 1991-07-10 | 1994-01-10 | Menetelmiä liikehermotautien hoitamiseksi käyttäen BDNF/NT-3/NGF -molekyyliperheen jäseniä |
Country Status (20)
Country | Link |
---|---|
EP (2) | EP0755682A1 (de) |
JP (1) | JPH06509094A (de) |
CN (1) | CN1065768C (de) |
AT (1) | ATE202939T1 (de) |
AU (2) | AU675409B2 (de) |
CA (1) | CA2113083A1 (de) |
DE (1) | DE69231930T2 (de) |
DK (1) | DK0593516T3 (de) |
ES (1) | ES2157903T3 (de) |
FI (1) | FI940098A (de) |
GR (1) | GR3036776T3 (de) |
HU (1) | HUT70275A (de) |
IE (1) | IE921602A1 (de) |
IL (1) | IL101928A0 (de) |
NO (1) | NO940084L (de) |
PT (1) | PT100501A (de) |
RU (1) | RU94016525A (de) |
SK (1) | SK2694A3 (de) |
WO (1) | WO1993001300A1 (de) |
ZA (1) | ZA923639B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2137799A1 (en) * | 1992-06-12 | 1993-12-23 | Nancy Ip | Therapeutic and diagnostic methods based on neurotrophin-4 expression |
FR2717496B1 (fr) * | 1994-03-18 | 1996-04-12 | Rhone Poulenc Rorer Sa | Virus recombinants, préparation et utilisation en thérapie génique. |
CN1112215C (zh) * | 1999-12-28 | 2003-06-25 | 潘晓东 | 神经生长因子在治疗有机溶剂中毒性周围神经病中的用途 |
US7741310B2 (en) | 2000-05-05 | 2010-06-22 | Research Foundation Of The City University Of New York | Methods for stimulating nervous system regeneration and repair by regulating arginase I and polyamine synthesis |
IN2014CN03629A (de) * | 2004-11-17 | 2015-09-04 | Neuralstem Inc | |
WO2008156418A1 (en) * | 2007-06-19 | 2008-12-24 | Astrazeneca Ab | A method for screening or diagnosis of postpolio syndrome and fibromyalgia |
ME00977B (me) * | 2007-08-10 | 2012-06-20 | Regeneron Pharma | Humana antitijela visokog afiniteta prema humanom nervnom faktoru rasta |
WO2014111525A2 (en) | 2013-01-18 | 2014-07-24 | Anaxomics Biotech, Sl | New combination therapies for treating nervous system diseases |
US10349890B2 (en) | 2015-06-26 | 2019-07-16 | C. R. Bard, Inc. | Connector interface for ECG-based catheter positioning system |
WO2023164311A2 (en) * | 2022-02-28 | 2023-08-31 | Bioincept, Llc | Compositions and methods of treating amyotrophic lateral sclerosis (als) and related disorders |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4923696A (en) * | 1987-05-04 | 1990-05-08 | Baylor College Of Medicine | Method to prepare a neurotrophic composition |
GR1000980B (el) * | 1989-08-30 | 1993-03-31 | Max Planck Gesellschaft | Νευροτροφινη-3,ενας νεος neυροτροφικος παραγοντας που σχετιζεται με τον παραγοντα αναπτυξης νευρων και τον νευροτροφικο παραγοντα που προερχεται απο τον εγκεφαλο. |
US5229500A (en) * | 1989-08-30 | 1993-07-20 | Regeneron Pharmaceuticals, Inc. | Brain derived neurotrophic factor |
IE903130A1 (en) * | 1989-09-15 | 1991-03-27 | Regeneron Pharma | Ciliary neurotrophic factor |
-
1992
- 1992-05-19 EP EP96111711A patent/EP0755682A1/de not_active Withdrawn
- 1992-05-19 RU RU94016525/14A patent/RU94016525A/ru unknown
- 1992-05-19 AU AU20095/92A patent/AU675409B2/en not_active Ceased
- 1992-05-19 ES ES92912453T patent/ES2157903T3/es not_active Expired - Lifetime
- 1992-05-19 ZA ZA923639A patent/ZA923639B/xx unknown
- 1992-05-19 CA CA2113083A patent/CA2113083A1/en not_active Abandoned
- 1992-05-19 WO PCT/US1992/004228 patent/WO1993001300A1/en active IP Right Grant
- 1992-05-19 EP EP92912453A patent/EP0593516B1/de not_active Expired - Lifetime
- 1992-05-19 DE DE69231930T patent/DE69231930T2/de not_active Expired - Lifetime
- 1992-05-19 JP JP5502202A patent/JPH06509094A/ja active Pending
- 1992-05-19 HU HU9400063A patent/HUT70275A/hu unknown
- 1992-05-19 CN CN92105070A patent/CN1065768C/zh not_active Expired - Fee Related
- 1992-05-19 IL IL101928A patent/IL101928A0/xx unknown
- 1992-05-19 PT PT100501A patent/PT100501A/pt not_active Application Discontinuation
- 1992-05-19 AT AT92912453T patent/ATE202939T1/de not_active IP Right Cessation
- 1992-05-19 SK SK26-94A patent/SK2694A3/sk unknown
- 1992-05-19 DK DK92912453T patent/DK0593516T3/da active
- 1992-07-01 IE IE160292A patent/IE921602A1/en not_active Application Discontinuation
-
1994
- 1994-01-10 FI FI940098A patent/FI940098A/fi not_active Application Discontinuation
- 1994-01-10 NO NO940084A patent/NO940084L/no unknown
-
1996
- 1996-11-08 AU AU70676/96A patent/AU7067696A/en not_active Abandoned
-
2001
- 2001-10-03 GR GR20010401637T patent/GR3036776T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ES2157903T3 (es) | 2001-09-01 |
HU9400063D0 (en) | 1994-06-28 |
AU675409B2 (en) | 1997-02-06 |
ATE202939T1 (de) | 2001-07-15 |
CA2113083A1 (en) | 1993-01-21 |
DE69231930T2 (de) | 2002-04-11 |
EP0593516B1 (de) | 2001-07-11 |
GR3036776T3 (en) | 2002-01-31 |
EP0593516A1 (de) | 1994-04-27 |
DK0593516T3 (da) | 2001-09-17 |
CN1065768C (zh) | 2001-05-16 |
NO940084D0 (no) | 1994-01-10 |
EP0593516A4 (de) | 1995-01-18 |
WO1993001300A1 (en) | 1993-01-21 |
EP0755682A1 (de) | 1997-01-29 |
DE69231930D1 (de) | 2001-08-16 |
PT100501A (pt) | 1993-09-30 |
AU2009592A (en) | 1993-02-11 |
HUT70275A (en) | 1995-09-28 |
IL101928A0 (en) | 1992-12-30 |
ZA923639B (en) | 1993-02-24 |
CN1071585A (zh) | 1993-05-05 |
RU94016525A (ru) | 1996-06-10 |
SK2694A3 (en) | 1995-02-08 |
AU7067696A (en) | 1997-01-16 |
JPH06509094A (ja) | 1994-10-13 |
FI940098A0 (fi) | 1994-01-10 |
NO940084L (no) | 1994-03-08 |
IE921602A1 (en) | 1993-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI940098A (fi) | Menetelmiä liikehermotautien hoitamiseksi käyttäen BDNF/NT-3/NGF -molekyyliperheen jäseniä | |
NO951592L (no) | Fremgangsmåte for fremstilling av et transdermalt terapeutisk system | |
FI108146B (fi) | Biologisesti aktiivisten, neurotrofisten NGF/BDNF-sarjan yhdistelmäproteiinien valmistus | |
ATE88900T1 (de) | Konjugate von interferon alpha mit immunglobulinen. | |
AU6909091A (en) | Neurologic agents for nasal administration to the brain | |
PT97552A (pt) | Processo para a preparacao de formas de dosagem para administracao de farmacos para o tratamento da doenca de parkison | |
DE59108854D1 (de) | Arzneimittel sowie deren herstellung und deren verwendung bei der bekämpfung von schmerzen und/oder entzündungen an tieren und menschen | |
ATE213411T1 (de) | Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen | |
DE69033703D1 (de) | Nichtglykosyliertes fgf-4 und dieses enthaltende präparate | |
DE3782346D1 (de) | Verwendung von chinolon und naphthyridin-antibiotika zur herstellung von ophthalmischen arzneimitteln. | |
DE3770465D1 (de) | Verwendung von zinn-protoporphyrin und zinn-mesoporphyrin zur herstellung eines arzneimittels fuer die behandlung von psoriasis. | |
EE03017B1 (et) | Kõrge eriaktiivsusega ja teraapiliseks kasutamiseks sobiv vere XI hüübimisteguri kontsentraat ning meetod selle saamiseks | |
AU7426487A (en) | Method of treating depression using d-fenfluramine | |
Gordon | The relationship between language and behaviour. | |
MD1716C2 (ro) | Utilizare a melatoninei pentru tratamentul pacienţilor dependenţi de benzodiazepine | |
Aurela | A systematic storytelling therapy. | |
Bogdanov et al. | Methods for the restoration of motor functions in patients with acute and early recovery periods of cerebral stroke | |
Semke | Feasibility of pathogenetic therapy for hysteria | |
DE19739761A1 (de) | Verwendung von Ozon und zusätzlich noch dosierte Vitamin E Indikation zur Blutbehandlung | |
RU96117545A (ru) | Способ лечения диабетической ретинопатии | |
RU93008692A (ru) | Способ рефлексотерапии | |
UA20012A (uk) | Спосіб лікуваhhя постекстракційhої запальhої ексудативhої реакції у хворих hа катаракту |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |